Myasthenia gravis: Association of british neurologists’ management guidelines

Practical Neurology

Volumn 15, Issue 3, 2015, Pages 199-206

  Sussman, Jon ^a   Farrugia, Maria E ^b   Maddison, Paul ^c   Hill, Marguerite ^d   Leite, M Isabel ^e   Hilton Jones, David ^e  

^a Greater Manchester Neurosciences Centre   (United Kingdom)

^b SOUTHERN GENERAL HOSPITAL   (United Kingdom)

^c QUEEN S MEDICAL CENTRE   (United Kingdom)

^d MORRISTON HOSPITAL   (United Kingdom)

^e JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE INHIBITOR; PYRIDOSTIGMINE;

DISEASE MANAGEMENT; GREAT BRITAIN; HUMAN; MYASTHENIA GRAVIS; NEUROLOGY; PROCEDURES; STANDARDS;

CHOLINESTERASE INHIBITORS; DISEASE MANAGEMENT; GREAT BRITAIN; HUMANS; MYASTHENIA GRAVIS; NEUROLOGY; PYRIDOSTIGMINE BROMIDE;

EID: 84929322495     PISSN: 14747758     EISSN: 14747766     Source Type: Journal    
DOI: 10.1136/practneurol-2015-001126     Document Type: Article

References (5)

1. Jacob S, Viegas S, Lashley D, et al. The Bare Essentials: Myasthenia gravis and other neuromuscular junction disorders. Pract Neurol 2009;9:364–71.
2. Hilton-Jones D. What to do when… The patient fails to respond to treatment: myasthenia gravis. Pract Neurol 2007;7:405–11.
3. Elsais A, Argov Z, Evoli A, et al. EFNS/ENS Guidelines for the treatment of ocular myasthenia. Eur J Neurol 2014;21:687–93.
4. Palace J, Newsom-Davis J, Lecky B. A randomised double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis. Neurology 1998;50:1778–83.
5. Norwood F, Dhanjal M, Hill M, et al. Myasthenia in pregnancy: best practice guidelines from a UK multispecialty working group. J Neurol Neurosurg Psychiatry 2014;85:538–43.